InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Landau Jeffrey B. Director active across 1 company, notably CytomX Therapeutics, Inc.. Cumulatively, 9 reports have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €20k. Activity tracked since 19 July 2022. The latest transaction was filed on 20 August 2024 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Landau Jeffrey B is a declarant. He has 9 filings in total, and across the sampled recent filings between 2022-07-21 and 2024-08-22, sales total EUR 20473 and the modal transaction nature is Attribution. He is linked to CytomX Therapeutics, Inc., where his listed role is Chief Business Officer.